We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+4.67%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.05B
AUM Growth
+$276M
(+4.1%)
Cap. Flow
+$73M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
27.96%
Holding
1,430
New
433
Increased
334
Reduced
305
Closed
319
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$182M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$170M |
| 3 |
AET
Aetna Inc
AET
|
+$131M |
| 4 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
+$108M |
| 5 |
Brookdale Senior Living
BKD
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$435M |
| 2 |
Elevance Health
ELV
|
+$121M |
| 3 |
Cigna
CI
|
+$119M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
+$82.7M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$72.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.34% |
| 2 | Financials | 7.86% |
| 3 | Consumer Discretionary | 7.17% |
| 4 | Technology | 6.32% |
| 5 | Industrials | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FNSR
251
DELISTED
Finisar Corp
FNSR
| $5.87M | 0.08% |
328,471
+136,652
| +71% | +$2.9M |
|
252
Truist Financial
TFC
$63.3B
| $5.87M | 0.08% |
145,511
+105,582
| +264% | +$4.18M |
|
253
Skyworks Solutions
SWKS
$9.37B
| $5.86M | 0.08% |
56,283
-2,477
| -4% | -$251K |
|
|
NVCN
254
DELISTED
Neovasc Inc.
NVCN
| $5.83M | 0.08% |
34
-2
| -6% | -$387K |
|
255
Enlivex Ltd
ENLV
$35.2M
| $5.82M | 0.08% |
1,407
| – | – |
|
256
EOG Resources
EOG
$79.2B
| $5.7M | 0.08% |
65,080
+62,714
| +2,651% | +$5.8M |
|
257
Boot Barn
BOOT
$4.51B
| $5.69M | 0.08% |
177,835
-5,499
| -3% | -$144K |
|
258
Fastenal
FAST
$54.7B
| $5.69M | 0.08% |
539,536
+240,848
| +81% | +$2.53M |
|
259
Cisco
CSCO
$457B
| $5.59M | 0.08% |
203,570
-318,986
| -61% | -$9.15M |
|
260
JB Hunt Transport Services
JBHT
$25.5B
| $5.48M | 0.08% |
66,760
+60,752
| +1,011% | +$5.28M |
|
261
SolarEdge
SEDG
$2.51B
| $5.45M | 0.08% |
150,000
+75,000
| +100% | +$2.41M |
|
|
FCS
262
DELISTED
FAIRCHILD SEMICONDUCTOR INTL INC COMMON
FCS
| $5.35M | 0.08% |
307,943
-477,154
| -61% | -$9.15M |
|
|
PLL
263
DELISTED
PALL CORP
PLL
| $5.3M | 0.08% |
42,579
+39,034
| +1,101% | +$4.41M |
|
|
TFCF
264
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $5.2M | 0.07% |
161,397
-199,027
| -55% | -$6.6M |
|
265
Metallus
MTUS
$838M
| $5.19M | 0.07% |
192,315
+31,615
| +20% | +$933K |
|
266
Xenon Pharmaceuticals
XENE
$6.06B
| $5.19M | 0.07% |
450,000
-25,000
| -5% | -$346K |
|
267
Clearwater Paper
CLW
$339M
| $5.16M | 0.07% |
90,067
+2,170
| +2% | +$134K |
|
|
ALR
268
DELISTED
AlerisLife Inc
ALR
| $5.16M | 0.07% |
+107,461
| New | +$4.88M |
|
269
Western Digital
WDC
$188B
| $5.13M | 0.07% |
86,569
-38,345
| -31% | -$2.75M |
|
|
AVNS
270
DELISTED
Avanos Medical
AVNS
| $5.11M | 0.07% |
+126,100
| New | +$5.66M |
|
271
Zevra Therapeutics
ZVRA
$562M
| $5.11M | 0.07% |
+17,375
| New | +$3.79M |
|
|
FCH
272
DELISTED
Felcor Lodging Trust
FCH
| $5.09M | 0.07% |
+515,000
| New | +$5.63M |
|
273
Radware
RDWR
$1.1B
| $5.04M | 0.07% |
+227,100
| New | +$5.28M |
|
274
Huntsman Corp
HUN
$1.71B
| $4.96M | 0.07% |
224,489
-307,009
| -58% | -$6.95M |
|
|
TCON
275
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $4.94M | 0.07% |
2,182
-125
| -5% | -$293K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2015 Portfolio in Review
As of Q2 2015, Visium Asset Management held 1,430 positions worth $7.05B, up 4.1% from $6.78B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Visium Asset Management's Q2 2015 filing shows 433 new, 334 increased, 305 reduced and 319 closed positions. Its largest new stake was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M. The largest sale was Allergan plc, an estimated $435M.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
- Visium Asset Management's largest Q2 2015 buy was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M.
- Visium Asset Management added most to Bausch Health in Q2 2015, an estimated $182M increase.
- Visium Asset Management's biggest Q2 2015 reduction was Elevance Health, cutting an estimated $121M.
- Visium Asset Management fully exited Allergan plc in Q2 2015, selling an estimated $435M.
- Visium Asset Management's ten largest holdings make up 28% of its $7.05B portfolio in Q2 2015.
- Visium Asset Management opened 433 new positions and closed 319 in Q2 2015.
- Visium Asset Management's portfolio value rose 4.1% quarter-over-quarter to $7.05B.
Based on Visium Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.